ANAB Earnings Anaptysbio, Inc
Reported EPS, revenue and net income by fiscal period (SEC EDGAR) — quarterly and annual. Full financials → Chart & overview → Latest filing
Annual results
EPS
Revenue
Net income
Quarterly results
EPS
Revenue
Net income
Reported EPS history
1–49 of 49
| Q1 2026 | 2026-03-31 | -1.84 | 2026-05-12 | 10-Q |
| Q4 2025 (derived) | 2025-12-31 | 1.64 | 2026-03-03 | 10-K |
| FY 2025 | 2025-12-31 | -0.46 | 2026-03-03 | 10-K |
| Q3 2025 | 2025-09-30 | 0.52 | 2025-11-04 | 10-Q |
| Q2 2025 | 2025-06-30 | -1.34 | 2025-08-06 | 10-Q |
| Q1 2025 | 2025-03-31 | -1.28 | 2025-05-05 | 10-Q |
| Q4 2024 (derived) | 2024-12-31 | -0.63 | 2025-02-27 | 10-K |
| FY 2024 | 2024-12-31 | -5.12 | 2025-02-27 | 10-K |
| Q3 2024 | 2024-09-30 | -1.14 | 2024-11-05 | 10-Q |
| Q2 2024 | 2024-06-30 | -1.71 | 2024-08-05 | 10-Q |
| Q1 2024 | 2024-03-31 | -1.64 | 2024-05-09 | 10-Q |
| Q4 2023 (derived) | 2023-12-31 | -1.59 | 2024-03-11 | 10-K |
| FY 2023 | 2023-12-31 | -6.08 | 2024-03-11 | 10-K |
| Q3 2023 | 2023-09-30 | -1.41 | 2023-11-02 | 10-Q |
| Q2 2023 | 2023-06-30 | -1.50 | 2023-08-07 | 10-Q |
| Q1 2023 | 2023-03-31 | -1.58 | 2023-05-11 | 10-Q |
| Q4 2022 (derived) | 2022-12-31 | -0.93 | 2023-03-01 | 10-K |
| FY 2022 | 2022-12-31 | -4.57 | 2023-03-01 | 10-K |
| Q3 2022 | 2022-09-30 | -1.18 | 2022-11-08 | 10-Q |
| Q2 2022 | 2022-06-30 | -1.15 | 2022-08-08 | 10-Q |
| Q1 2022 | 2022-03-31 | -1.31 | 2022-05-04 | 10-Q |
| Q4 2021 (derived) | 2021-12-31 | -1.19 | 2022-03-07 | 10-K |
| FY 2021 | 2021-12-31 | -2.11 | 2022-03-07 | 10-K |
| Q3 2021 | 2021-09-30 | -0.24 | 2021-11-04 | 10-Q |
| Q2 2021 | 2021-06-30 | -0.02 | 2021-08-09 | 10-Q |
| Q1 2021 | 2021-03-31 | -0.66 | — | — |
| FY 2020 | 2020-12-31 | -0.73 | — | — |
| Q3 2020 | 2020-09-30 | -0.87 | — | — |
| Q2 2020 | 2020-06-30 | -0.79 | — | — |
| Q4 2019 | 2019-12-31 | -0.75 | 2020-03-02 | 10-K |
| FY 2019 | 2019-12-31 | -3.60 | 2020-03-02 | 10-K |
| Q3 2019 | 2019-09-30 | -1.15 | — | — |
| Q2 2019 | 2019-06-30 | -0.89 | — | — |
| Q1 2019 | 2019-03-31 | -0.82 | — | — |
| Q4 2018 | 2018-12-31 | -0.64 | 2019-02-28 | 10-K |
| FY 2018 | 2018-12-31 | -2.50 | 2019-02-28 | 10-K |
| Q3 2018 | 2018-09-30 | -0.66 | — | — |
| Q2 2018 | 2018-06-30 | -0.57 | — | — |
| Q1 2018 | 2018-03-31 | -0.63 | — | — |
| Q4 2017 | 2017-12-31 | -0.30 | 2018-03-05 | 10-K |
| FY 2017 | 2017-12-31 | -1.52 | 2018-03-05 | 10-K |
| Q3 2017 | 2017-09-30 | -0.45 | 2017-11-07 | 10-Q |
| Q2 2017 | 2017-06-30 | -0.13 | 2017-08-10 | 10-Q |
| Q1 2017 | 2017-03-31 | -0.75 | — | — |
| Q4 2016 | 2016-12-31 | -1.73 | — | — |
| FY 2016 | 2016-12-31 | -1.62 | — | — |
| Q3 2016 | 2016-09-30 | -0.42 | — | — |
| Q2 2016 | 2016-06-30 | 0.05 | — | — |
| Q1 2016 | 2016-03-31 | -0.34 | — | — |
Source: SEC EDGAR / XBRL (reported actuals; no consensus estimates). Some issuers (e.g. mortgage REITs, banks) don't report a conventional revenue line, so those charts may be omitted. Q4 EPS marked "derived" is computed as the fiscal-year EPS minus Q1–Q3 (10-Ks report only the annual figure); EPS is not strictly additive across quarters, so it can differ by a cent or two from the issuer's own Q4. A period with no "Reported" date is known only from a later filing's prior-year comparative. Informational only — not financial advice.